Navigation Links
Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
Date:4/29/2009

ise sufficient funds for development or working capital; that Raptor may be unsuccessful in developing any products or acquiring products; that Raptor's technology may not be validated as it progresses further and its methods may not be accepted by the scientific community; that Raptor is unable to retain or attract key employees whose knowledge is essential to the development of its products; that unforeseen scientific difficulties develop with the Company's process; that Raptor's patents are not sufficient to protect essential aspects of its technology; that competitors may invent better technology; and that Raptor's products may not work as well as hoped or worse, that the Company's products may harm recipients. and. As well, Raptor's products may never develop into useful products and even if they do, they may not be approved for sale to the public. Raptor cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in the Company's filings from time to time with the Securities and Exchange Commission (the "SEC"), which Raptor strongly urges you to read and consider, including its Registration Statement on Form S-1, as amended, that was declared effective on August 7, 2008; its annual report on Form 10-K filed with the SEC on October 30, 2008, as amended by Forms 10-K/A filed with the SEC on December 23, 2008 and April 20, 2009; and its Form 10-Q filed with the SEC on April 13, 2009, all of which are available free of charge on the SEC's web site at http://www.sec.gov. Subsequent written and oral forward-looking statements attributable to Raptor or to persons -acting on its behalf are expressly qualified in their entirety by the cautionary statements set forth in the Company's reports filed with the SEC. Raptor expressly disclaims any intent or obligation t
'/>"/>
SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Provides Update of Product Programs
2. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
5. Raptor Pharmaceuticals Provides Update on Targeting Platforms
6. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
9. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... BETHESDA, Md. , March 2, 2015 ... on treating and preventing autoimmune diseases, announced today that ... (AMG 714) from Amgen (NASDAQ: AMGN ). ... has the rights to develop, manufacture and commercialize AMG ... . Concurrently, Amgen has been granted an exclusive ...
(Date:3/2/2015)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ... clinical grade hypothermic storage and cryopreservation ... for cells and tissues  ("BioLife" or the "Company"), ... Company its 2015 Silver Awardee for Achievement in Medical ... Michael Romoser described the environment for the awards ...
(Date:3/2/2015)... , Abbott Diabetes Care, American Association of ... Apple, Arkray, Asante Solutions, A. Menarini, Bayer ... Carewell Biotech, Centres for Medicare and Medicaid ... for Disease Control and Prevention (CDC), Carlyle ... Chugai, Conceptus, Covidien, Cygnus, ConvaTec, Constitution Medical ...
Breaking Medicine Technology:Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3BioLife Solutions Wins Washington State 2015 Silver Award for Achievement in Medical Technology from Seattle Business Magazine 2BioLife Solutions Wins Washington State 2015 Silver Award for Achievement in Medical Technology from Seattle Business Magazine 3Blood Glucose Meters Industry 2019 Forecasts for Global and Chinese Regions 2
... honored 12 outstanding PhD students and two professors with the ... in the field of organic chemistry. The winners are participating ... in Chemistry to gain first hand knowledge on the ... "These students come from a broad range of universities ...
... 2011 Echo Therapeutics, Inc. (OTCBB: ... as a non-invasive, wireless, transdermal continuous glucose monitoring ... transdermal drug delivery, announced that it has received ... tCGM System design.  This newly-engineered design is currently ...
Cached Medicine Technology:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 2Echo Therapeutics Announces Symphony™ tCGM System Progress 2Echo Therapeutics Announces Symphony™ tCGM System Progress 3
(Date:3/2/2015)... 2015 The Workgroup for Electronic Data ... use of health IT to create efficiencies in healthcare ... for Small Providers.” The white paper by WEDI’s ICD-10 ... for ICD-10 testing by focusing on primary considerations and ... with the October 1, 2015 implementation date. Download the ...
(Date:3/2/2015)... 02, 2015 The minimally invasive ... a CAGR of 6.1% to reach $14,133.0 million ... , Factors such as advantages of minimally invasive ... owing to minimally invasive surgeries and increasing number ... driving the global minimally invasive surgical instruments market. ...
(Date:3/2/2015)... TX (PRWEB) March 02, 2015 ... lot easier thanks to the success of ... meal planning easy and delicious for thousands of ... positive customer feedback by expanding to offer a ... Tastes, which features seasonally appropriate classic recipes and ...
(Date:3/2/2015)... WI (PRWEB) March 02, 2015 ... consultancy focused on quality, regulatory and technical consulting, ... as Chief Operating Officer. , Before joining ... experience leading R&D teams in all aspects of ... leadership positions at Covidien (Medtronic), Regulatory Compliance Associates ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 What are ... should physicians request references? When are interviews scheduled, how ... employment opportunities?, Both training and practicing physicians who are ... these questions and more at the PracticeLink Physician Career ... The drop-in Job Fair is from 5:30 to 8:30 ...
Breaking Medicine News(10 mins):Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2
... David Bereit, director of the nation-wide ... reinvigorated the grassroots pro-life movement, will be ... Jan. 23, 2009.(Logo: http://www.newscom.com/cgi-bin/prnh/20081105/DC44231LOGO )Bereit,s revolutionary ... community outreach touched 204 cities across 49 ...
... changes can make all the difference , , TUESDAY, Dec. ... that continues to sweep across the United States has ... disease, up more than 3 million people since 2005. ... wave of illnesses and disabilities brought on by diabetes ...
... adults and 19 percent of children taking chemotherapy drugs in ... or experienced other mistakes involving their medications, according to a ... of pediatrics at the University of Massachusetts Medical School, and ... Journal of Clinical Oncology . , "As cancer care continues ...
... therapeutic range of utmost importance, study finds , , TUESDAY, ... can be highly effective in preventing strokes and treating ... best way manage the drug therapy. , Boston University ... figured out the optimal dosing levels to help patients, ...
... Resort & Spa,is proud to announce the debut of ... in time for holiday travelers. The resort,s Venus ... the size of the pre-,existing facility to 27,000 sq. ... Club Room, VIP suite, an expansive fitness center,relaxation room ...
... , ... Rosemont, IL (Vocus) December 30, 2008 -- Utilizing an Automated ... at an athletic event can mean the difference between life and death ... a study published in the inaugural edition of Sports Health : ...
Cached Medicine News:Health News:40 Days for Life Leader to Speak at Personhood Conference 2Health News:America Losing the Fight With Type 2 Diabetes 2Health News:America Losing the Fight With Type 2 Diabetes 3Health News:Errors involving medications common in outpatient cancer treatment 2Health News:Optimal Warfarin Dosing Improves Anticoagulation Control 2Health News:CuisinArt Resort & Spa Debuts $10 Million Expansion of World-Class Venus Spa 2Health News:Study Stresses Importance of Availability of Automated External Defibrillators at Athletic Events 2Health News:Study Stresses Importance of Availability of Automated External Defibrillators at Athletic Events 3
... the pioneers of surgical lighting, including ... automatic reserve bulb, an integrated surgical ... sets the standard for advanced lighting ... our latest generation surgical light ...
... SimpliCT® is an interventional guidance device ... significantly improve the accuracy of computed ... to improving accuracy, SimpliCT® also has ... of CT-guided puncture procedures including biopsies ...
Flat tip, bare fiber, no cooling, polished SMA 905, 3 meters long. Sold in boxes of five. Each part is individually packaged in sterile Tyvek bags....
Get YAG laser performance from your diode laser. Our proprietary NA shift technology offers efficient coupling of low divergence fiber to high divergence lasers...
Medicine Products: